The Chronic Lymphocytic Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ERIC 2022 | Preventing severe COVID-19 infection in patients with CLL
Yair Herishanu, MD, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel, comments on the management of patients with chronic lymphocytic leukemia (CLL) to prevent severe infection with COVID-19, highlighting the importance of immunization and prophylaxis. This interview took place at the 2022 European Research Initiative on CLL (ERIC) Meeting.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
